<VariationArchive VariationID="449691" VariationName="NM_006073.4(TRDN):c.438_442del (p.Asp146_Lys147insTer)" VariationType="Deletion" Accession="VCV000449691" Version="4" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-08" DateCreated="2017-12-19" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="443865" VariationID="449691">
      <GeneList>
        <Gene Symbol="TRDN" FullName="triadin" GeneID="10345" HGNC_ID="HGNC:12261" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="123216339" stop="123636950" display_start="123216339" display_stop="123636950" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="123537483" stop="123958237" display_start="123537483" display_stop="123958237" Strand="-" />
          </Location>
          <OMIM>603283</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_006073.4(TRDN):c.438_442del (p.Asp146_Lys147insTer)</Name>
      <CanonicalSPDI>NC_000006.12:123530547:TCTTATCTT:TCTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q22.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="123530548" stop="123530552" display_start="123530548" display_stop="123530552" variantLength="5" positionVCF="123530547" referenceAlleleVCF="GTCTTA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="123851693" stop="123851697" display_start="123851693" display_stop="123851697" variantLength="5" positionVCF="123851692" referenceAlleleVCF="GTCTTA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.123851697_123851701del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.123851697_123851701del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.123530552_123530556del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.123530552_123530556del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_030438.1" sequenceAccession="NG_030438" sequenceVersion="1" change="g.111542_111546del">
            <Expression>NG_030438.1:g.111542_111546del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001251987.2" sequenceAccession="NM_001251987" sequenceVersion="2" change="c.438_442del">
            <Expression>NM_001251987.2:c.438_442del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001238916.1" sequenceAccession="NP_001238916" sequenceVersion="1" change="p.Asp146_Lys147insTer">
            <Expression>NP_001238916.1:p.Asp146_Lys147insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256020.2" sequenceAccession="NM_001256020" sequenceVersion="2" change="c.438_442del">
            <Expression>NM_001256020.2:c.438_442del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242949.1" sequenceAccession="NP_001242949" sequenceVersion="1" change="p.Asp146_Lys147insTer">
            <Expression>NP_001242949.1:p.Asp146_Lys147insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256021.2" sequenceAccession="NM_001256021" sequenceVersion="2" change="c.438_442del">
            <Expression>NM_001256021.2:c.438_442del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242950.1" sequenceAccession="NP_001242950" sequenceVersion="1" change="p.Asp146_Lys147insTer">
            <Expression>NP_001242950.1:p.Asp146_Lys147insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256022.2" sequenceAccession="NM_001256022" sequenceVersion="2" change="c.438_442del">
            <Expression>NM_001256022.2:c.438_442del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242951.1" sequenceAccession="NP_001242951" sequenceVersion="1" change="p.Asp146_Lys147insTer">
            <Expression>NP_001242951.1:p.Asp146_Lys147insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407315.1" sequenceAccession="NM_001407315" sequenceVersion="1" change="c.438_442del">
            <Expression>NM_001407315.1:c.438_442del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394244.1" sequenceAccession="NP_001394244" sequenceVersion="1" change="p.Asp146_Lys147insTer">
            <Expression>NP_001394244.1:p.Asp146_Lys147insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006073.4" sequenceAccession="NM_006073" sequenceVersion="4" change="c.438_442del" MANESelect="true">
            <Expression>NM_006073.4:c.438_442del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006064.2" sequenceAccession="NP_006064" sequenceVersion="2" change="p.Asp146_Lys147insTer">
            <Expression>NP_006064.2:p.Asp146_Lys147insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006073.2" sequenceAccession="NM_006073" sequenceVersion="2" change="c.438_442delTAAGA">
            <Expression>NM_006073.2:c.438_442delTAAGA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA3984381" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603283.0004" DB="OMIM" />
        <XRef Type="rs" ID="752256846" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff established an HGVS expression for this deletion from the trace in Figure 2 of the paper by Altmann et al., 2015 (PubMed 25922419).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006073.4(TRDN):c.438_442del (p.Asp146_Lys147insTer) AND not provided" Accession="RCV000519867" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006073.4(TRDN):c.438_442del (p.Asp146_Lys147insTer) AND Catecholaminergic polymorphic ventricular tachycardia 1" Accession="RCV003525916" Version="1">
        <ClassifiedConditionList TraitSetID="6589">
          <ClassifiedCondition DB="MedGen" ID="C1631597">Catecholaminergic polymorphic ventricular tachycardia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006073.4(TRDN):c.438_442del (p.Asp146_Lys147insTer) AND Catecholaminergic polymorphic ventricular tachycardia 5" Accession="RCV003985018" Version="1">
        <ClassifiedConditionList TraitSetID="11990">
          <ClassifiedCondition DB="MedGen" ID="C3809536">Catecholaminergic polymorphic ventricular tachycardia 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006073.4(TRDN):c.438_442del (p.Asp146_Lys147insTer) AND Cardiovascular phenotype" Accession="RCV004023546" Version="1">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-22" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2017-12-19" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22422768</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25922419</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26200674</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27848944</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30649896</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6589" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4488" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC 1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia 1</ElementValue>
                <XRef ID="MONDO:0011484" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Stress-induced polymorphic ventricular tachycardia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CPVT1</ElementValue>
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C1631597" DB="MedGen" />
              <XRef ID="MONDO:0011484" DB="MONDO" />
              <XRef Type="MIM" ID="604772" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="11990" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18303" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia 5</ElementValue>
                <XRef ID="MONDO:0014191" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARDIAC ARRHYTHMIA SYNDROME, WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS</ElementValue>
                <XRef Type="MIM" ID="615441" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CARDAR</ElementValue>
                <XRef Type="MIM" ID="615441" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15967" />
                <XRef ID="15967" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C3809536" DB="MedGen" />
              <XRef ID="MONDO:0014191" DB="MONDO" />
              <XRef Type="MIM" ID="615441" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1204446" SubmissionDate="2019-01-29" DateLastUpdated="2017-12-19" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDX:931204|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000618034" DateUpdated="2017-12-19" DateCreated="2017-12-19" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.438_442delTAAGA variant in the TRDN gene has been reported as a homozygous variant in three patients with LQTS (Altmann et al., 2015). This variant results in the replacement of a lysine residue with a premature stop codon at position 147 and is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Other loss of function variants in the TRDN gene have been reported in Human Gene Mutation Database in association with arrhythmia (Stenson et al., 2014). Furthermore, the c.438_442delTAAGA variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRDN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006073.3:c.438_442delTAAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3550590" SubmissionDate="2021-09-16" DateLastUpdated="2021-09-19" DateCreated="2021-08-27">
        <ClinVarSubmissionID localKey="603283.0004_CARDIAC ARRHYTHMIA SYNDROME WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS" title="TRDN, 5-BP DEL, 572TAAGA_CARDIAC ARRHYTHMIA SYNDROME WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS" />
        <ClinVarAccession Accession="SCV001809804" DateUpdated="2021-09-19" DateCreated="2021-08-27" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 unrelated children (families 2, 3, and 4) with cardiac arrhythmia syndrome (CARDAR; 615441) who experienced syncope or cardiac arrest before 3 years of age and had long QT intervals on electrocardiography, Altmann et al. (2015) identified homozygosity for a 5-bp deletion (c.572_576delTAAGA, NM_001256021.1) in the TRDN gene, resulting in an immediate stop codon (Lys147fsTer0). One child (family 2) also exhibited mild proximal muscle weakness, and another (family 4) showed polymorphic and bidirectional ventricular tachycardia on electrocardiography, in addition to transient QT prolongation. A fourth child (family 5), who experienced cardiac arrest at age 20 months and exhibited mild to moderate skeletal muscle weakness and decreased muscle tone at age 4 years, was compound heterozygous for the 5-bp deletion and a splicing mutation (c.22+29A-G; 603283.0005). The mutations segregated with disease in the respective families, and were either not found or were present at very low minor allele frequency in public variant databases.</Attribute>
              <Citation>
                <CitationText>Altmann, H. M., Tester, D. J., Will, M. L., Middha, S., Evans, J. M., Eckloff, B. W., Ackerman, M. J. Homozygous/compound heterozygous triadin mutations associated with autosomal-recessive long-QT syndrome and pediatric sudden cardiac arrest: elucidation of the triadin knockout syndrome. Circulation 131: 2051-2060, 2015.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="615441" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRDN" />
          </GeneList>
          <Name>TRDN, 5-BP DEL, 572TAAGA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DEL, 572TAAGA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603283.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CARDIAC ARRHYTHMIA SYNDROME WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8005566" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="2357453|MedGen:C1631597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004323476" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22422768</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25922419</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26200674</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30649896</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25922419</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys147*) in the TRDN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRDN are known to be pathogenic (PMID: 22422768, 25922419, 26200674, 30649896). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with TRDN-related conditions (PMID: 25922419). This variant is also known as c.del 572_576 TAAGA (p.K147fs*0). ClinVar contains an entry for this variant (Variation ID: 449691). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRDN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.123851693_123851697del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1631597" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9233965" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2024-05-01">
        <ClinVarSubmissionID localKey="a680455|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005024440" DateUpdated="2024-05-01" DateCreated="2024-05-01" Type="SCV" Version="1" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25922419</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27848944</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30649896</ID>
          </Citation>
          <Comment>The c.438_442delTAAGA pathogenic mutation, located in coding exon 5 of the TRDN gene, results from a deletion of 5 nucleotides at nucleotide positions 438 to 442, causing a translational frameshift with a predicted alternate stop codon (p.K147*). This variant has been detected in unrelated homozygous probands with features of long QT syndrome, catecholaminergic polymorphic ventricular tachycardia and/or skeletal muscle weakness (Altmann HM et al. Circulation, 2015 Jun;131:2051-60; Trujillano D et al. Eur J Hum Genet, 2017 Feb;25:176-182; Clemens DJ et al. Circ Genom Precis Med, 2019 Feb;12:e002419). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRDN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006073.2:c.438_442delTAAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1204446" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9233965" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8005566" TraitType="Disease" MappingType="XRef" MappingValue="C1631597" MappingRef="MedGen">
        <MedGen CUI="C1631597" Name="Catecholaminergic polymorphic ventricular tachycardia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3550590" TraitType="Disease" MappingType="Name" MappingValue="CARDIAC ARRHYTHMIA SYNDROME WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS" MappingRef="Preferred">
        <MedGen CUI="C3809536" Name="Catecholaminergic polymorphic ventricular tachycardia 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

